Overexpression of ARNT2 is associated with decreased cell proliferation and better prognosis in gastric cancer
Aryl hydrocarbon-receptor nuclear translocator (ARNT2) is a member of the bHLH PAS (basic helix–loop–helix Period/ARNT/Single-minded) family of transcription factors. Recently, some studies indicate that ARNT2 is associated with the occurrence and development of carcinoma. However, its roles in gastric cancer (GC) remain unclear. In the present study, we found that ARNT2 expression level is lower in GC tissues compared with adjacent non-tumor tissues, and negatively correlated with depth of invasion of the tumor, differentiated degree, and poor survival of GC patients. Overexpression of ARNT2 inhibits cell proliferation. Furthermore, AKT pathway contributed to ARNT2 -mediated PC proliferation. Taken together, our results provide the first evidence that high expression of ARNT2 inhibited proliferation of GC cells and affected tumor aggressiveness in GC patients.
KeywordsAryl hydrocarbon-receptor nuclear translocator (ARNT2) Gastric cancer (GC) Proliferation
This work was financially supported by the National Natural Science Foundation of China (No. 31671468 and 81602593), the Chinese Postdoctoral Science Foundation (No. 2016M602152), the Shandong Provincial Natural Science Foundation of China (No. 2016ZRA01062, ZR2015HM018, ZR2017MH071, and ZR2012HM061), and the Jinan Postdoctoral Innovation Project (172634).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Liou JM, Fang YJ, Chen CC, Bair MJ, Chang CY, Lee YC, Chen MJ, Chen CC, Tseng CH, Hsu YC, Lee JY, Yang TH, Luo JC, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hu WH, Chen YN, Sheu BS, Lin JT, Wu JY, El-Omar EM, Wu MS, Taiwan Gastrointestinal D, Helicobacter C (2016) Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet 388(10058):2355–2365. https://doi.org/10.1016/S0140-6736(16)31409-X CrossRefGoogle Scholar
- 2.Hirose K, Morita M, Ema M, Mimura J, Hamada H, Fujii H, Saijo Y, Gotoh O, Sogawa K, Fujii-Kuriyama Y (1996) cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt). Mol Cell Biol 16(4):1706–1713CrossRefGoogle Scholar
- 8.Zudaire E, Cuesta N, Murty V, Woodson K, Adams L, Gonzalez N, Martinez A, Narayan G, Kirsch I, Franklin W, Hirsch F, Birrer M, Cuttitta F (2008) The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. J Clin Investig 118(2):640–650. https://doi.org/10.1172/JCI30024 Google Scholar
- 14.Qin XY, Zaha H, Nagano R, Yoshinaga J, Yonemoto J, Sone H (2011) Xenoestrogens down-regulate aryl-hydrocarbon receptor nuclear translocator 2 mRNA expression in human breast cancer cells via an estrogen receptor alpha-dependent mechanism. Toxicol Lett 206(2):152–157. https://doi.org/10.1016/j.toxlet.2011.07.007 CrossRefGoogle Scholar
- 17.Qin XY, Wei F, Yoshinaga J, Yonemoto J, Tanokura M, Sone H (2011) siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells. FEBS Lett 585(20):3310–3315. https://doi.org/10.1016/j.febslet.2011.09.017 CrossRefGoogle Scholar